Lv31
388 积分 2026-07-25 加入
PLIN2 Promotes Lipid Accumulation in Ascites‐Associated Macrophages and Ovarian Cancer Progression by HIF1α/SPP1 Signaling
6小时前
已完结
Metabolic reprogramming and molecular crosstalk at the cancer-endothelial interface in ovarian carcinoma
4天前
已完结
The Molecular Mechanisms of Actions, Effects, and Clinical Implications of PARP Inhibitors in Epithelial Ovarian Cancers: A Systematic Review
22天前
已完结
Repression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repair
22天前
已完结
Intermittent olaparib with neoadjuvant platinum-based chemotherapy in BRCA-mutated un-resectable ovarian cancer: the NUVOLA trial
28天前
已完结
PARP inhibitors in ovarian cancer: Mechanisms of resistance and implications to therapy
28天前
已完结
Novel Approaches for Detecting TP53 Mutations and Targeted Therapeutic Strategies: Emerging Insights Into Cytoplasmic p53 Aggregates in Ovarian Cancer
28天前
已完结
The Molecular Landscape of Ovarian Neoplasms
28天前
已关闭
基于二代测序技术探讨卵巢癌同源重组修复缺陷基因检测
28天前
已完结
BRCA1/2 -stratified immune profiling of treatment-naive high-grade serous ovarian cancer ascites identifies a Treg-enriched ascitic immune phenotype
28天前
已完结
皖公网安备34019202002308
